Pranayama and Jacobson's Progressive Muscle Relaxation Technique in Pre-hypertensive Patients
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Oct 23, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a randomized controlled trial used to determine the effects of Pranayama and Jacobson's progressive muscle relaxation technique on Cardiovascular parameters, Stress and Quality of Life in Prehypertensive Patients.
A Nonprobability Convenient Sampling Technique will be used and random allocation into groups using the Lottery method. Patients will be assigned into 2 groups i.e. Group A \& Group B Group A: will receive Pranayama. Pranayama is the practice of breath regulation. It's a main component of yoga, an exercise for physical and mental wellness. The practice of pranayama involv...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: Participants must be between 30 and 60 years old.
- • Gender: Male and Female both.
- • Diagnosed patients of Pre-hypertension.
- • Stable health condition to participate in moderate physical activities.
- • Willing to comply with the study protocol, including attending scheduled exercise sessions and follow-up assessments
- Exclusion Criteria:
- • Diagnosed case of Hypertension or takes any antihypertensive medication.
- • Patient having any other associated systemic disorder are excluded.
- • Severe physical limitations, disabilities, or musculoskeletal disorders.
- • History of substance abuse.
- • Patients with Neurological diseases
- • Patients with severe or unstable heart conditions, recent heart attack, or heart failure, other cardiovascular disorders
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sialkot, Punjab, Pakistan
Patients applied
Trial Officials
Sumera AbdulHameed Supervisor/ Research Incharge, M.PHIL
Principal Investigator
Riphah International University Lahore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported